Related Experiment Video
Updated: Jul 5, 2026

Donor Posterior Atrial Flap Rotation for Left Atrial Cuff Reconstruction in Lung Transplantation
Published on: October 11, 2024
Ross Operation with decellularized pulmonary allografts: medium-term results
Francisco Costa1, Pascal Dohmen, Eduardo Vieira
1Medicine Department - PUCPR. fcosta@mps.com.br
Decellularized allografts used in the Ross Operation demonstrated safety and efficacy over four years. Sodium dodecylsulfate (SDS) treated grafts showed a trend toward lower pressure gradients post-surgery.
Area of Science:
- Cardiovascular Surgery
- Biomaterials Science
- Regenerative Medicine
Background:
- The Ross Operation is a surgical procedure to replace a diseased aortic valve with the patient's own pulmonary valve.
- Decellularized allografts offer a potential alternative to cryopreserved allografts, aiming to reduce immunogenicity and improve tissue integration.
- Medium-term outcomes of decellularized allografts in the Ross Operation require further evaluation.
Purpose of the Study:
- To assess the medium-term (4-year) clinical outcomes of decellularized allografts utilized in the Ross Operation.
- To compare the hemodynamic performance and structural integrity of decellularized allografts against cryopreserved allografts.
Main Methods:
- A cohort of 68 patients undergoing Ross Operation with decellularized allografts (decellularized with deoxycholic acid or sodium dodecylsulfate) were followed for 4 years.
- Hemodynamic data was collected via echocardiography, with comparisons made to a matched cohort receiving cryopreserved allografts.
- Histological analysis and MRI studies were performed to evaluate tissue regeneration and conduit characteristics.
Main Results:
- One early death (1.4%) and two late reoperations for endocarditis were reported. No progressive pulmonary insufficiency was observed.
- Echocardiography showed stable pressure gradients over time, with no significant difference compared to cryopreserved allografts, although a trend towards lower gradients was noted in the sodium dodecylsulfate group after 12 months.
- Histology confirmed partial reendothelialization and cellular repopulation, while MRI indicated a reduced tendency for shrinkage in decellularized conduits.
Conclusions:
- Decellularized allografts are safe for the Ross Operation, yielding favorable medium-term results up to 4 years.
- Sodium dodecylsulfate decellularized allografts may offer an advantage with potentially lower late pressure gradients.
More Related Videos
10:13Transplantation of Bioengineered Lung Using Decellularized Mouse Lungs and Primary Human Endothelial Cells
Published on: March 28, 2025
09:54Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
Published on: August 15, 2022